Supreme Court Dismisses Appeal on Directors' Liability in Drug Manufacturing Case Due to Sufficient Allegations. Directors Linked to Defective Drug Manufacturing Under Section 34(2) of the Drugs & Cosmetics Act, 1940.

  • 0
Judgement Image
Font size:
Print

Case Note & Summary

The case involved an appeal against the High Court's dismissal of a petition under Section 482 of the Code of Criminal Procedure, 1973 (Cr.P.C.) concerning the prosecution of directors of a company for manufacturing a defective drug. The High Court had ruled that the directors could be held liable under Section 34(2) of the Drugs & Cosmetics Act, 1940, as they were responsible for the company's affairs. The appellants contended that the complaint failed to establish their active involvement in the alleged offence, citing a lack of specific allegations against them. The court examined the language of the complaint, noting that it included statements indicating the directors' involvement in the manufacturing process, which was critical given the public health implications of the defective drug. The court distinguished this case from a precedent where the prosecution was quashed due to insufficient allegations against the directors. Ultimately, the Supreme Court upheld the High Court's decision, emphasizing that the directors could present their defense in the Trial Court regarding their involvement in the manufacturing process. The appeal was dismissed, affirming the High Court's order.

Headnote

A) Criminal Law - Directors' Liability - Vicarious Liability of Directors - Drugs & Cosmetics Act, 1940, Section 34(2) - The court held that mere directorship does not imply liability unless active involvement in the offence is established. The complaint contained specific allegations linking the directors to the manufacturing process, thus justifying the prosecution under the Act. Held that the High Court's dismissal was appropriate (Paras 2-10).

Subscribe to unlock Headnote Subscribe Now

Issue of Consideration

Whether the High Court erred in dismissing the petition under Section 482 Cr.P.C. regarding the prosecution of directors for a defective drug manufactured by the company.

Subscribe to unlock Issue of Consideration Subscribe Now

Final Decision

The Supreme Court dismissed the appeal, affirming the High Court's order that the directors could be prosecuted under Section 34(2) of the Drugs & Cosmetics Act, 1940, based on the allegations in the complaint.

Law Points

  • Criminal liability of directors
  • Vicarious liability
  • Section 34(2) Drugs & Cosmetics Act
  • 1940
  • Section 482 Cr.P.C.
  • Public health implications
Subscribe to unlock Law Points Subscribe Now

Case Details

2010 LawText (SC) (08) 109

Criminal Appeal No. 1464 of 2010

2010-08-06

V.S. Sirpurkar, Cyriac Joseph

H.A. Raichura

Dinesh B. Patel & Ors.

State of Gujarat & Anr.

Subscribe to unlock Case Details (Citation, Judge, Date & more) Subscribe Now

Nature of Litigation

Appeal against High Court's dismissal of a petition under Section 482 Cr.P.C.

Remedy Sought

Appellants sought to quash the complaint against them.

Filing Reason

Complaint alleged that the drug manufactured was defective, implicating the directors.

Previous Decisions

High Court dismissed the petition, ruling that the directors could be prosecuted.

Issues

Whether the High Court erred in dismissing the petition under Section 482 Cr.P.C. Whether the complaint sufficiently alleged the directors' involvement in the offence.

Submissions/Arguments

Appellants argued that the complaint lacked specific allegations of directors' involvement. Respondents contended that the complaint included sufficient allegations linking directors to the manufacturing process.

Ratio Decidendi

Directors can be held liable under Section 34(2) of the Drugs & Cosmetics Act if the complaint establishes their involvement in the manufacturing process, distinguishing from cases requiring specific averments under other statutes.

Judgment Excerpts

The High Court took the view that the directors are responsible for the affairs of the company. The complaint filed against the directors could not be disposed of under Section 482 Cr.P.C. as it required appreciation of the facts. The emphasized portion in para 6 of the complaint suggests manufacturing of the medicine by the company and its directors.

Procedural History

The appeal arose from a Special Leave Petition dismissed by the Supreme Court, with notice issued for remaining appellants after the dismissal of the petition by the High Court.

Acts & Sections

  • Drugs & Cosmetics Act, 1940: Section 34(2)
  • Code of Criminal Procedure, 1973: Section 482
Subscribe to unlock full Legal Analysis Subscribe Now
Related Judgement
High Court Bombay High Court Dismisses Tenants' Second Appeal in Rent Control Case — Notification Under Bombay Rent Act Not Applicable to Karjat Village for Mixed-Use Premises. The Court held that the tenant failed to prove that the notification extending the...
Related Judgement
High Court Madras High Court Disposes Writ Petition Directing Transport Corporation to Pay Surrender Leave Encashment with Interest. Mandamus Issued to Enforce Retired Employee's Right to Terminal Benefits.